Filip is Senior Investment Manager Fund Investments since November 2023, joining from PMV’s LS&C Equity Investment team.
He has +25 years of experience in corporate development and venture capital (Vives, SGS, Abbott, Innogenetics and J&J).
Filip currently holds (advisory) board member positions at the following funds Kurma Growth Opportunities Fund, Forbion Growth Fund I, Droia Invest II, Droia Genetic Disease, Novalis II, OMXE Partners, V-bio Fund I and V-bio Fund II. Prior to his move in Fund Investments Filip held positions in the Board of inter alia Confo therapeutics, Aphea, Syndesi and animal health company Virovet.
Filip holds a Ph.D. in Pharmaceutical Sciences from Antwerp and is guest lecturer on Venture capital at UGent, and at the Solvay Advanced Master in Biotech and MedTech Ventures.